Literature DB >> 17476100

Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community.

Laure Carcaillon1, Karine Pérès, Jean-Jacques Péré, Catherine Helmer, Jean-Marc Orgogozo, Jean-François Dartigues.   

Abstract

BACKGROUND/AIMS: Current findings suggest the existence of a category of fast cognitive decliners with a poorer prognosis but better treatment response. Our study aimed at confirming the concept of fast decliners at the time of Alzheimer's disease (AD) diagnosis which best predicts mortality, in an unselected sample.
METHODS: 245 incident cases of AD were selected from the French longitudinal cohort PAQUID. We investigated a different threshold of cognitive decline [measured by the annual loss of points in the Mini Mental State Examination (MMSE) score] to define when a subject could be considered as a fast decliner. We used Cox proportional hazards models to study the relation between cognitive decline and mortality.
RESULTS: The significant threshold of decline associated with a higher mortality rate was a loss of 3 points per year in the MMSE score. Among the 245 AD cases, 83 (33.9%) subjects were considered as fast decliners. Of them, 78.3% died during the follow-up compared with 63.0% of the slow decliners (RR = 1.7, 95% CI 1.2-2.5).
CONCLUSION: These results constitute an empirical validation of the concept of fast decliners in community-based AD patients and justify the cutoff of 3 points for the definition of this condition.

Entities:  

Mesh:

Year:  2007        PMID: 17476100     DOI: 10.1159/000102017

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  20 in total

1.  Rapid cognitive decline in Alzheimer's disease. Consensus paper.

Authors:  M E Soto; S Andrieu; C Arbus; M Ceccaldi; P Couratier; T Dantoine; J-F Dartigues; S Gillette-Guyonnet; F Nourhashemi; P-J Ousset; M Poncet; F Portet; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

2.  Factors affecting survival of patients with neurodegenerative disease.

Authors:  Kyle Steenland; Jessica MacNeil; Ryan Seals; Allan Levey
Journal:  Neuroepidemiology       Date:  2010-04-08       Impact factor: 3.282

3.  Trail Making Test predicts physical impairment and mortality in older persons.

Authors:  Rosamaria Vazzana; Stefania Bandinelli; Fabrizio Lauretani; Stefano Volpato; Fulvio Lauretani; Angelo Di Iorio; Michele Abate; Anna Maria Corsi; Yuri Milaneschi; Jack M Guralnik; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2010-04       Impact factor: 5.562

4.  Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients.

Authors:  Konstantinos Stellos; Victoria Panagiota; Andreas Kögel; Thomas Leyhe; Meinrad Gawaz; Christoph Laske
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-18       Impact factor: 6.200

5.  Diagnosis of Alzheimer's disease patients with rapid cognitive decline in clinical practice: interest of the Deco questionnaire.

Authors:  L Carcaillon; G Berrut; F Sellal; J F Dartigues; S Gillette; J J Pere; I Bourdeix
Journal:  J Nutr Health Aging       Date:  2011-05       Impact factor: 4.075

6.  Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities.

Authors:  Giuseppe Tosto; Molly E Zimmerman; Owen T Carmichael; Adam M Brickman
Journal:  JAMA Neurol       Date:  2014-07-01       Impact factor: 18.302

7.  Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons.

Authors:  Peter T Nelson; Erin L Abner; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Charles D Smith; Daron G Davis; John W Poduska; Ela Patel; Marta S Mendiondo; William R Markesbery
Journal:  Brain Pathol       Date:  2008-11-19       Impact factor: 6.508

8.  Oral disease in relation to future risk of dementia and cognitive decline: prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial.

Authors:  G-D Batty; Q Li; R Huxley; S Zoungas; B-A Taylor; B Neal; B de Galan; M Woodward; S-B Harrap; S Colagiuri; A Patel; J Chalmers
Journal:  Eur Psychiatry       Date:  2011-10-02       Impact factor: 5.361

9.  Using the Guttman scale to define and estimate measurement error in items over time: the case of cognitive decline and the meaning of "points lost".

Authors:  Rochelle E Tractenberg; Futoshi Yumoto; Paul S Aisen; Jeffrey A Kaye; Robert J Mislevy
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

10.  Cognitive function and 10 year mortality in an 85 year-old community-dwelling population.

Authors:  Yutaka Takata; Toshihiro Ansai; Inho Soh; Shuji Awano; Ikuo Nakamichi; Sumio Akifusa; Kenichi Goto; Akihiro Yoshida; Hiroki Fujii; Ritsuko Fujisawa; Kazuo Sonoki
Journal:  Clin Interv Aging       Date:  2014-10-07       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.